Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1998-09-03
1999-12-14
Wilson, James O.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
424427, 514 54, 514912, 514 25, 514 27, 514456, 514457, B32B 300
Patent
active
060013680
ABSTRACT:
A method is provided for inhibiting or reducing the risk of macular degeneration with phytoestrogenic isoflavones. A further method is provided for inhibiting or reducing the risk of macular degeneration with a soy protein material containing phytoestrogenic isoflavones.
REFERENCES:
patent: 4157984 (1979-06-01), Zilliken
patent: 4218489 (1980-08-01), Zilliken
patent: 4232122 (1980-11-01), Zilliken
patent: 4264509 (1981-04-01), Zilliken
patent: 4366082 (1982-12-01), Zilliken
patent: 4366248 (1982-12-01), Zilliken
patent: 5141746 (1992-08-01), Fleury et al.
patent: 5506211 (1996-04-01), Barnes et al.
patent: 5603936 (1997-02-01), Monte
Isoflavone Contend in Commercial Soybean Foods, Wang and Murphy, J. Agric. Food Chem., vol. 42, No. 8, pp. 1666-1673 (1994).
Abstract--Effect of Soybean Isoflavones on Tumor Promoter--Induced H.sub.2 O.sub.2 Production in Human Neutrophils and HL-60 Cells, Wei and Barnes, Proceedings of the American Association for Cancer Research, vol. 34, p. 167 (Mar. 1993).
The Flavanoids, Advances in Research Since 1980, ed. J.B. Harbone, Chapman and Hall, Chapter 5, pp. 125-209 (1988).
Isoflavone Composition of American and Japanese Soybeans in Iowa: Effects of Variety, Crop Year, and Location, Wang and Murphy, J. Agric. Food Chem., vol. 42, pp. 1674-1677 (1994).
Genistein, A Specific Inhibitor of Tyrosine-specific Protein Kinases, Akiyama, Ishida, Nakagawa, Ogawara, Watanabe, Itoh, Shibuya, and Fukami, J. Biological Chem., vol. 262, No. 12, pp. 5592-5595 (Apr. 25, 1986).
Soybeans: Chemistry and Technology, pp. 187-188 (1978).
Control of Serum Lipids with Soy Protein, Erdman, New England J. of Med., vol. 333, No. 5, pp. 313-315 (Aug. 3, 1995).
Soybean Utilization, Chapter 2--Morphology and Composition, pp. 64-66 (1987).
Meta-analysis of the Effects of Soy Protein Intake on Serum Lipids, Anderson, Johnstone, and Cook-Newell, New England J. of Med., vol. 333, No. 5, pp. 276-282 (Aug. 3, 1995).
Soy Isoflavones Enhance Coronary Vascular Reactivity in Atherosclerotic Female Macaques, Honore, Williams, Anthony and Clarkson, Fertil. Steril., vol. 67, No. 1, pp. 148-154 (Jan. 1997).
Soy Protein and Serum Lipids, Potter, Curr. Opin. Lipidol., vol. 7, No. 4, pp. 260-264 (Aug. 1996).
Soybean Isoflavones Improve Cardiovascular Risk Factors Without Affecting the Reproductive System of Peripubertal Rhesus Monkeys, Anthony, Clarkson, Hughes, Morgan and Burke, J. Nutr., vol. 126, No. 1, pp. 43-50 (Jan. 1996).
Biology of Atherosclerotic Placque Formation: Possible Role of Growth Factors in Lesion Development and the Potential Impact of Soy, Raines and Ross, J. Nutr., vol. 125, Supp. 3, pp. 624s-630s (Mar. 1995).
Inhibition of Tyrosine Phosphorylation Prevents Delayed Neuronal Death Following Cerebral Ischemia, Kindy, J. Cereb. Blood Flow Metab., vol. 13, No. 3, pp. 372-377 (May 1993).
Health Relevance of Soya Beans Due to their Isoflavonoid Content, Bohm and Franke, Z. Lenensmittelwirtsch, vol. 47, No. 12, pp. 55-57 (1996).
Soy in the Spotlight, Kuhn, Food Process., vol. 57, No. 5, pp. 52-58 (1996).
Chemical Constitution and Biological Activity of Plants of the Clover Genus Trifolium L., Babaskin, Barabanov and Babaskina, Farmatsiya Moscow, vol. 38, No. 3, 78-82 (1989).
Modern Uses for an Ancient Bean: Soyfoods and Disease, Messina, Chem. Ind., vol. 11, pp. 412-415 (1995).
A Review of the Clinical Effects of Phytoestrogens, Knight and Eden, Obstetrics and Gynecology, vol. 87, No. 5, pp. 897-904 (May 1996).
Phytoestrogens--A Short Review, Knight and Eden, Maturitas, vol. 22, No. 3, pp. 167-175 (Nov. 1995).
Symposia: Examining the Benefits of Dietary Phytoestrogens, Inpharma, Dec. 6, 1996.
Estrogen Effect on Atherogenesis and Vascular Biology, Williams (WFU), Federal Research in Process 1996, Sponsoring Org.: National Heart, Lung and Blood Inst.
Ostrogenic Effects of Plant Foods in Postmenopausal Women, Wilcox, Wahlqvist, Burger and Medley, Br. Med. J., vol. 301, pp. 905-906 (1990).
Reproductive and General Metabolic Effects of Phytoestrogens in Mammals, Kaladas and Hughes, Reproductive Technology, vol. 3, pp. 81-89 (1989).
Naturally Occuring Oestrogens in Foods--a Review, Price and Fenwick, Food Additives and Contaminants, vol. 2, No. 2, pp. 73-106 (1985).
The Chemistry of Subterranean Clover. Part I. Isolation of Formononetin and Genistein, Bradbury and White, (1951).
Determination of Lignans and Isoflavanoids in Human Female Plasma Following Dietary Supplementation, Wilcox, Wahlqvist and Griffiths, J. of Endocrinology, vol. 142(2), pp. 251-259 (1994).
Dietary Carbohydrates and Low Cholesterol Diets: Effects of Serum Lipids of Man, Hodges et al., Am. J. Clin. Nutr., vol. 20, No. 2, pp. 196-208 (Feb. 1967).
Soy Protein and Serum Lipids, Potter, Current Opinion in Lipidology, vol. 7, pp. 260-264 (1996).
Quantitation of Phytoestrogens in Legumes by HPLC, Franke et al., J. Agric. Food Chem., vol. 42, pp. 1905-1913 (1994).
Phytoestrogens: Epidemiology and a Possible Role in Cancer Protection, Adlercreutz, Environ. health Perspect., vol. 103, pp. 103-112 (1995).
A Review of Phytoestrogens and Their Effects in Relation to Menopausal Symptoms, Knight et al., Australian J. of Nut. And Dietetics, 53:1, pp. 5-11 (1996).
Phytoestrogen Content of Processed Soybean Products, Murphy, Food Technology, pp. 60, 62-64 (Jan. 1982).
Naturally Occurring Non-Steroidal Estrogens of Dietary Origin, Setchell, Estrogens in the Environment, J. McLachlen, Editor, pp. 69-85.
An Extract of Soy Flour Influences Serum Cholesterol and Thyroid Hormones in Rats and Hamsters, Balmir, F. et al., J. Nutr., 126: 3046-3053 (1996).
Protein Technologies International, Inc.
Taylor Richard B.
Wilson James O.
LandOfFree
Method for inhibiting or reducing the risk of macular degenerati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting or reducing the risk of macular degenerati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting or reducing the risk of macular degenerati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-860542